Top compounds associated with response to CD300LD


Feature Type Standardized
Nominal ANOVA
mRNA AC220 GDSC1000 pan-cancer AAC 0.066 0.05
mRNA phenformin GDSC1000 pan-cancer AAC 0.059 0.05
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.062 0.05
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.061 0.05
mRNA Cisplatin GDSC1000 pan-cancer AAC 0.064 0.06
mRNA Axitinib GDSC1000 pan-cancer AAC 0.067 0.06
mRNA CGP-082996 GDSC1000 pan-cancer AAC 0.1 0.06
mRNA foretinib GDSC1000 pan-cancer AAC 0.06 0.06
mRNA T0901317 GDSC1000 pan-cancer AAC 0.061 0.06
mRNA JQ12 GDSC1000 pan-cancer AAC 0.064 0.06
Download CSV